4,5,6,7-四氢-1,3-苯并噻唑-2-甲醛 | 884504-72-7

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 4,5,6,7-四氢-1,3-苯并噻唑-2-甲醛
• 英文名称: 4,5,6,7-tetrahydrobenzo[d]thiazole-2-carbaldehyde
• 英文别名: 4,5,6,7-Tetrahydro-1,3-benzothiazole-2-carbaldehyde
• CAS: 884504-72-7
• 化学式: C₈H₉NOS
• mdl: MFCD05864486
• 分子量: 167.232
• InChiKey: DKERWJOGOMSSOG-UHFFFAOYSA-N

物化性质

• 沸点：
  321.2±45.0 °C(Predicted)
• 密度：
  1.280±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  58.2
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2934200090

反应信息

• 作为反应物：
  描述：

  4,5,6,7-四氢-1,3-苯并噻唑-2-甲醛 、 5-amino-6-(cyclopropylmethylamino)-3-methyl-1H-pyrimidine-2,4-dione 以 甲苯 为溶剂， 反应 1.0h， 生成 6-(cyclopropylmethylamino)-3-methyl-5-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-ylmethylideneamino)-1H-pyrimidine-2,4-dione
  参考文献：
  名称：

  Synthesis of Novel 3,7-Dihydro-purine-2,6-dione Derivatives

  摘要：

  Forty-six novel 3,7-dihydro-purine-2,6-dione derivatives (substituted xanthines) with great structural diversity were synthesized for biological activity screening. Three series of substituted xanthine analogs have been prepared in moderate to excellent yields.

  DOI：

  10.1080/00397910903097260

文献信息

• [EN] PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY<br/>[FR] DÉRIVÉS DE PYRROLIDINE, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, ET LEUR UTILISATION EN THÉRAPIE
  申请人：ABBVIE DEUTSCHLAND

  公开号：WO2014140310A1

  公开（公告）日：2014-09-18

  The present invention relates to pyrrolidine derivatives of formula (I), or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such pyrrolidine derivatives, and the use of such pyrrolidine derivatives for therapeutic purposes. The pyrrolidine derivatives are GlyT1 inhibitors.

  本发明涉及式(I)的吡咯烷衍生物，或其生理耐受盐。该发明涉及包含此类吡咯烷衍生物的药物组合物，以及利用此类吡咯烷衍生物进行治疗的用途。这些吡咯烷衍生物是GlyT1抑制剂。
• [EN] NOVEL BIFUNCTIONAL MOLECULES FOR TARGETED PROTEIN DEGRADATION<br/>[FR] NOUVELLES MOLÉCULES BIFONCTIONNELLES POUR LA DÉGRADATION CIBLÉE DE PROTÉINES
  申请人：AMPHISTA THERAPEUTICS LTD

  公开号：WO2022129925A1

  公开（公告）日：2022-06-23

  The present disclosure relates to a novel class of bifunctional molecules that are useful in a targeted or selective degradation of a protein.

  本公开涉及一种新型的双功能分子，可用于有针对性或选择性地降解蛋白质。
• Bi-functional complexes and methods for making and using such complexes
  申请人：Gouliaev Alex Haahr

  公开号：US11225655B2

  公开（公告）日：2022-01-18

  The present invention is directed to a method for the synthesis of a bi-functional complex comprising a molecule part and an identifier oligonucleotide part identifying the molecule part. A part of the synthesis method according to the present invention is preferably conducted in one or more organic solvents when a nascent bi-functional complex comprising an optionally protected tag or oligonucleotide identifier is linked to a solid support, and another part of the synthesis method is preferably conducted under conditions suitable for enzymatic addition of an oligonucleotide tag to a nascent bi-functional complex in solution.

  本发明涉及一种合成双功能复合物的方法，该复合物包括分子部分和识别分子部分的识别寡核苷酸部分。根据本发明的合成方法的一部分优选在一种或多种有机溶剂中进行，此时包含可选保护标签或寡核苷酸标识符的新生双功能复合物与固体支持物相连接，合成方法的另一部分优选在适合于将寡核苷酸标签酶加到溶液中的新生双功能复合物的条件下进行。
• BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES
  申请人：Nuevolution A/S

  公开号：EP2558577B1

  公开（公告）日：2018-12-12
• PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY
  申请人：AbbVie Deutschland GmbH & Co. KG

  公开号：EP2970215A1

  公开（公告）日：2016-01-20